These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27613200)

  • 1. Epigenetic mechanisms of macrophage activation in type 2 diabetes.
    Ahmed M; de Winther MPJ; Van den Bossche J
    Immunobiology; 2017 Oct; 222(10):937-943. PubMed ID: 27613200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Regulation of S100A9 and S100A12 Expression in Monocyte-Macrophage System in Hyperglycemic Conditions.
    Mossel DM; Moganti K; Riabov V; Weiss C; Kopf S; Cordero J; Dobreva G; Rots MG; Klüter H; Harmsen MC; Kzhyshkowska J
    Front Immunol; 2020; 11():1071. PubMed ID: 32582175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of macrophage activation in obesity-induced insulin resistance.
    Odegaard JI; Chawla A
    Nat Clin Pract Endocrinol Metab; 2008 Nov; 4(11):619-26. PubMed ID: 18838972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages and islet inflammation in type 2 diabetes.
    Eguchi K; Manabe I
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():152-8. PubMed ID: 24003932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inflammatory effect of epigenetic factors and modifications in type 2 diabetes.
    Akbari M; Hassan-Zadeh V
    Inflammopharmacology; 2020 Apr; 28(2):345-362. PubMed ID: 31707555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes.
    Fan R; Toubal A; Goñi S; Drareni K; Huang Z; Alzaid F; Ballaire R; Ancel P; Liang N; Damdimopoulos A; Hainault I; Soprani A; Aron-Wisnewsky J; Foufelle F; Lawrence T; Gautier JF; Venteclef N; Treuter E
    Nat Med; 2016 Jul; 22(7):780-91. PubMed ID: 27270589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics and Immunometabolism in Diabetes and Aging.
    Guzik TJ; Cosentino F
    Antioxid Redox Signal; 2018 Jul; 29(3):257-274. PubMed ID: 28891325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotlight on epigenetics as a missing link between obesity and type 2 diabetes.
    Dobosz AM; Dziewulska A; Dobrzyń A
    Postepy Biochem; 2018 Oct; 64(2):157-165. PubMed ID: 30656898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternatively activated macrophages in types 1 and 2 diabetes.
    Espinoza-Jiménez A; Peón AN; Terrazas LI
    Mediators Inflamm; 2012; 2012():815953. PubMed ID: 23326021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes.
    Zatterale F; Raciti GA; Prevenzano I; Leone A; Campitelli M; De Rosa V; Beguinot F; Parrillo L
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of M1-like macrophages in type 2 diabetic islets is followed by a systemic shift in macrophage polarization.
    Cucak H; Grunnet LG; Rosendahl A
    J Leukoc Biol; 2014 Jan; 95(1):149-60. PubMed ID: 24009176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise Review: Macrophages: Versatile Gatekeepers During Pancreatic β-Cell Development, Injury, and Regeneration.
    Van Gassen N; Staels W; Van Overmeire E; De Groef S; Sojoodi M; Heremans Y; Leuckx G; Van de Casteele M; Van Ginderachter JA; Heimberg H; De Leu N
    Stem Cells Transl Med; 2015 Jun; 4(6):555-63. PubMed ID: 25848123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Macrophage Polarization in Insulin Signaling and Sensitivity.
    Orliaguet L; Dalmas E; Drareni K; Venteclef N; Alzaid F
    Front Endocrinol (Lausanne); 2020; 11():62. PubMed ID: 32140136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and muscle-macrophage crosstalk in humans and mice: A systematic review.
    Rudrapatna S; Bhatt M; Wang KW; Bierbrier R; Wang PW; Banfield L; Elsheikh W; Sims ED; Peterson D; Thabane L; Tarnopolsky MA; Steinberg GR; Samaan MC
    Obes Rev; 2019 Nov; 20(11):1572-1596. PubMed ID: 31410961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Mechanisms in Monocytes/Macrophages Regulate Inflammation in Cardiometabolic and Vascular Disease.
    Davis FM; Gallagher KA
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):623-634. PubMed ID: 30760015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation as a diagnostic and therapeutic target in the battle against Type 2 diabetes.
    Rönn T; Ling C
    Epigenomics; 2015; 7(3):451-60. PubMed ID: 26077431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats.
    Xie Z; Hao H; Tong C; Cheng Y; Liu J; Pang Y; Si Y; Guo Y; Zang L; Mu Y; Han W
    Stem Cells; 2016 Mar; 34(3):627-39. PubMed ID: 26523620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, inflammation, and insulin resistance--a mini-review.
    Zeyda M; Stulnig TM
    Gerontology; 2009; 55(4):379-86. PubMed ID: 19365105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodontitis promotes the diabetic development of obese rat via miR-147 induced classical macrophage activation.
    Xu R; Zeng G; Wang S; Tao H; Ren L; Zhang Z; Zhang Q; Zhao J; Gao J; Li D
    Biomed Pharmacother; 2016 Oct; 83():892-897. PubMed ID: 27518498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.